Skip to content

VISION-3D: Virtual Imaging of Sarcoma: Interdisciplinary preOperative plaNning using 3D models

VISION-3D: Virtual Imaging of Sarcoma: Interdisciplinary preOperative plaNning using 3D models - VISION-3D

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00037314
Enrollment
200
Registered
2025-07-01
Start date
2025-08-01
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C49

Interventions

Group 1: In the control group, preoperative surgical planning is performed conventionally using two-dimensional cross-sectional imaging (CT/MRI). The imaging data are reviewed in the tumor board and d

Sponsors

Universitätsklinikum Hamburg-Eppendorf
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Diagnosis of a soft tissue sarcoma (abdominal, retroperitoneal, thoracic, or extremity) - Tumor size > cT1 - Locally resectable tumor (isolated or oligometastatic) - Written informed consent to participate in the study

Exclusion criteria

Exclusion criteria: - Emergency procedures - Time-critical indications that do not allow adequate preoperative planning (<48 hours until surgery) - Re-resections following R1/R2 resections - Purely diagnostic procedures (e.g., histological confirmation/incisional biopsies) - Change of the designated surgeon shortly before the operation

Design outcomes

Primary

MeasureTime frame
Reduction of operative time

Secondary

MeasureTime frame
- R0 resection rate - Deviations from the planned surgical strategy (based on a modified score, see below) - Intraoperative complications (e.g., blood loss) - Postoperative complications (e.g., wound infection) - Early complications ( 30 days postoperatively) - Limb, organ, and functional preservation - 30-day morbidity and mortality - Quality of life (patient-reported outcomes) - Length of hospital stay - Progression-free survival (PFS) and overall survival (OS)

Countries

Germany

Contacts

Public ContactAnna Duprée

Universitätsklinikum Hamburg-Eppendorf

adupree@uke.de+49 (0) 40 7410 - 535

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026